agilon health, inc.
AGL
$1.20
-$0.01-0.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.39B | 1.53B | 1.52B | 1.45B | 1.48B |
| Total Other Revenue | 2.94M | 2.90M | 3.24M | 3.24M | 3.18M |
| Total Revenue | 1.39B | 1.53B | 1.52B | 1.45B | 1.48B |
| Cost of Revenue | 1.45B | 1.48B | 1.56B | 1.52B | 1.45B |
| Gross Profit | -52.43M | 50.72M | -38.26M | -64.17M | 32.18M |
| SG&A Expenses | 56.16M | 65.43M | 59.91M | 61.67M | 68.74M |
| Depreciation & Amortization | 7.32M | 6.88M | 6.49M | 6.22M | 5.91M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51B | 1.55B | 1.63B | 1.58B | 1.53B |
| Operating Income | -115.91M | -21.59M | -104.66M | -132.06M | -42.48M |
| Income Before Tax | -104.31M | -1.69M | -104.67M | -117.02M | -30.25M |
| Income Tax Expenses | 62.00K | 196.00K | 1.76M | -590.00K | 417.00K |
| Earnings from Continuing Operations | -104.37M | -1.89M | -106.43M | -116.43M | -30.66M |
| Earnings from Discontinued Operations | -- | 14.00M | 640.00K | -1.18M | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | -- | -20.00K |
| Net Income | -104.37M | 12.11M | -105.79M | -117.62M | -30.68M |
| EBIT | -115.91M | -21.59M | -104.66M | -132.06M | -42.48M |
| EBITDA | -108.59M | -14.71M | -98.17M | -125.84M | -36.57M |
| EPS Basic | -0.25 | 0.03 | -0.26 | -0.29 | -0.07 |
| Normalized Basic EPS | -0.16 | 0.00 | -0.15 | -0.18 | -0.04 |
| EPS Diluted | -0.25 | 0.03 | -0.26 | -0.29 | -0.07 |
| Normalized Diluted EPS | -0.16 | 0.00 | -0.15 | -0.18 | -0.04 |
| Average Basic Shares Outstanding | 413.84M | 412.94M | 412.04M | 411.59M | 411.27M |
| Average Diluted Shares Outstanding | 413.84M | 412.94M | 412.04M | 411.59M | 411.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |